Medtronic PLC vs Twist Bioscience Corp — how do they compare? Medtronic PLC trades at $82.79 (market cap $106.61B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Medtronic PLC is far larger — about 19.6× Twist Bioscience Corp's market cap, and Medtronic PLC pays a 3.46% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| MDT | TWST | |
|---|---|---|
Market Cap | $106.61B | $5.45B |
Sector | Health | Health |
52-Week High | $105.35 | $102.88 |
52-Week Low | $73.75 | $24.16 |
Enterprise Value | $125.36B | $5.37B |
Dividend Yield | 3.46% | — |
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →